OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Examining new approaches, novel technologies, and the structural evolution of the raw materials market.
Advancements in soft capsule technology can enable the development of soft capsule formulations.
Alternative drug delivery formulation strategies can remove some drug dosage forms limitations.
January 03, 2023
Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023?
January 02, 2023
Manufacturers must consider key components of manufacturing solid versus semi-solid drugs to create a successful end product.
The latest report from Clarivate has been published, highlighting 15 potential blockbusters to watch out for in 2023, the majority of which are personalized medicines.
December 07, 2022
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
December 03, 2022
Unique solutions are required to protect inherently unstable messenger RNA.
Unique dosage forms, personalized medicine, and flexible manufacturing are possible with 3DP.
November 28, 2022
SPX-001, a respiratory drug candidate, will be submitted through a combined Clinical Trial and Ethics Committee application for further advancement in the clinical stages.
November 15, 2022
A look back at challenge and innovation highlights in 2022 for oral solid dosage forms, this podcast episode will review industry experts’ takes on factors driving the evolution of OSD forms as well as innovations in APIs, technology, and methodology.
November 03, 2022
Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration.
October 03, 2022
This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.